Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-05

Clinical Trial Update: Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Biological Sling Allograft (UVT) for urinary incontinence in women with synthetic sling complications has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biological Sling Allograft (UVT)

Snippet

Sponsor: TBF Genie Tissulaire | Conditions: Female Stress Incontinence, Stress Urinary Incontinence | Phase 2 | Status: COMPLETED